Skip to main content

Advertisement

SpringerLink
Log in

MRI with Gadoxetate Disodium for Colorectal Liver Metastasis: Is It the New “Imaging Modality of Choice”?

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Accurate detection of colorectal liver metastasis is paramount in the role of management. This study aims to compare magnetic resonance imaging (MRI) with gadoxetate disodium (a hepatocyte-specific agent—Eovist®) to triple-phase enhanced computed tomography in detecting colorectal liver metastases.

Methods

A retrospective chart analysis of 30 patients from 2011 to 2013 with colorectal liver metastases was performed. Patients with more than 6 weeks or two cycles of chemotherapy between the two imaging modalities were excluded. The number of lesions identified on triple-phase enhanced computed tomography vs. MRI with Eovist® was compared.

Results

Of the 30 patients that met the inclusion criteria, 12 (40 %) patients had more lesions identified on MRI with Eovist® compared to triple-phase enhanced computed tomography. Eighteen (60 %) had no change in the number of lesions identified. When MRI with Eovist® detected more lesions, the mean number of additional lesions detected was 1.5. Eovist® MRI changed the surgical management in 36.7 % of patients.

Conclusion

MRI with Eovist® is superior to enhanced computed tomography in identifying colorectal liver metastases. The increased number of lesion identified on MRI with Eovist® can profoundly change the surgeon’s management. It should be considered the “imaging modality of choice” in preoperative imaging for liver metastases in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mohammad WM, Balaa FK. Surgical management of colorectal liver metastases. Colon Rectal Surg 2009; 22(4): 225–232.

    Article  Google Scholar 

  2. Choi J. Imaging of hepatic metastases. Cancer Control 2006;13(1): 6–12.

    PubMed  Google Scholar 

  3. Lafaro KJ, Roumanis P, Demirjian AN, Lall C, Imagawa DK. Gd-EOB-DTPA-Enhanced MRI for detection of liver metastases from colorectal cancer. International Journal of Hepatology 2013; 2013:572307.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Leyendecker JR. Gadoxetate disodium for contrast MRI of the liver. Gastroenterology Hepatol, 2009; 5(10): 698.

    Google Scholar 

  5. Bakalakos EA, Kim JA, Young DC, Martin EW. Determinants of survival following hepatic resection or metastatic colorectal cancer. World J Surg 1998;22(4):399–404.

    Article  CAS  PubMed  Google Scholar 

  6. Sica GT, Ji H, Ros PR. CT and MR Imaging of hepatic metastases. American Journal of Roentgenology 2000; 174(3): 691–698.

    Article  CAS  PubMed  Google Scholar 

  7. Do RK, Rusinek H, Taouli B. Dynamic contrast-enhanced MRI of the liver: current status and future directions. MRI Clinics of North America 2009; 17(2): 339–349.

    PubMed  Google Scholar 

  8. Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ, Strotzer M, Taupitz M, Vogl TJ. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004; 230(1): 266–275.

    Article  PubMed  Google Scholar 

  9. Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomgvist L, Carter R, Grazioli L, Hammerstingl R, Huppertz A, Jung G, Krause D, Laghi A, Leen E, Lupatelli L, Marsili L, Martin J, Pretorius ES, Reinhold C, Stiskal M, Stolpen AH. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasicCT—a multicenter trial. Journal of Computer Assisted Tomography. 2006; 30(3): 345–354.

    Article  PubMed  Google Scholar 

  10. Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Investigative Radiology 2010; 45(3): 133–141.

    Article  PubMed  Google Scholar 

  11. Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, Fusté LC, Heinz-Peer G, Judmaier W, Laniado M, Manfredi RM, Mathieu DG, Müller D, Mortelè K, Reimer P, Reiser MF, Robinson PJ, Shamsi K, Strotzer M, Taupitz M, Tombach B, Valeri G, van Beers BE, Vogl TJ. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. European Radiology 2008; 18(3): 457–467.

    Article  PubMed  Google Scholar 

  12. Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA enhanced MRI. Journal of Nuclear Medicine 2010; 51(5): 692–699.

    Article  PubMed  Google Scholar 

  13. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Investigative Radiology 2011; 46(9): 548–555.

    Article  CAS  PubMed  Google Scholar 

  14. Chen L, Zhang J, Zhang L, Bao J, Liu C, Xia Y, Huang X, Wang J. Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One 2012; 7(11):e48681.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Berger-Kulemann V, Schima W, Baroud S, Koelblinger C, Kaczirek K, Gruenberger T, Schindl M, Maresch J, Weber M, BaSsalamah A. Gadoxetic acid-enhanced 3.0T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference. European Journal of Surgical Oncology 2012; 38(8): 670–676.

    Article  CAS  PubMed  Google Scholar 

  16. Zech CJ, Grazioli L, Jonas E, Ekman M, Niebecker R, Gschwend S, Breuer J, Jonsson L, Kienbaum S. Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs. extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italy and Sweden. European Radiology 2009; 19(3): S753–S763.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of HPB Surgery, Methodist Dallas Medical Center, 221 West Colorado Blvd, Pavilion 2, Suite 933, Dallas, TX, 75208, USA

    Shirali Patel, Houssam Osman & D. Rohan Jeyarajah

  2. Department of General Surgery, Cancer Center, Methodist Dallas Medical Center, 221 West Colorado Blvd, Pavilion 2, Suite 933, Dallas, TX, 75208, USA

    Susannah Cheek, Houssam Osman & D. Rohan Jeyarajah

Authors
  1. Shirali Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susannah Cheek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Houssam Osman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Rohan Jeyarajah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Rohan Jeyarajah.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patel, S., Cheek, S., Osman, H. et al. MRI with Gadoxetate Disodium for Colorectal Liver Metastasis: Is It the New “Imaging Modality of Choice”?. J Gastrointest Surg 18, 2130–2135 (2014). https://doi.org/10.1007/s11605-014-2676-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-014-2676-0

Keywords

Search

Navigation